Works by Muzikansky, Alona

Results: 92
    1

    Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104.

    Published in:
    Journal of Neuro-Oncology, 2025, v. 173, n. 3, p. 751, doi. 10.1007/s11060-025-05020-1
    By:
    • Nakhate, Vihang;
    • Ly, Ina;
    • Muzikansky, Alona;
    • Rapalino, Otto;
    • Allen, Jeffrey C.;
    • Blakeley, Jaishri O.;
    • Campian, Jian L.;
    • Clapp, D. Wade;
    • Dhall, Girish;
    • Jain, Rakesh K.;
    • Karajannis, Matthias A.;
    • Packer, Roger J.;
    • Tonsgard, James;
    • Ullrich, Nicole J.;
    • Korf, Bruce R.;
    • Fisher, Michael J.;
    • Plotkin, Scott R.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Phase 1/2 study of everolimus in advanced hepatocellular carcinoma.

    Published in:
    Cancer (0008543X), 2011, v. 117, n. 22, p. 5094, doi. 10.1002/cncr.26165
    By:
    • Zhu, Andrew X.;
    • Abrams, Thomas A.;
    • Miksad, Rebecca;
    • Blaszkowsky, Lawrence S.;
    • Meyerhardt, Jeffrey A.;
    • Zheng, Hui;
    • Muzikansky, Alona;
    • Clark, Jeffrey W.;
    • Kwak, Eunice L.;
    • Schrag, Deborah;
    • Jors, Kathryn R.;
    • Fuchs, Charles S.;
    • Iafrate, A. John;
    • Borger, Darrell R.;
    • Ryan, David P.
    Publication type:
    Article
    13
    14
    15

    Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2.

    Published in:
    Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad041
    By:
    • Jordan, Justin T;
    • Orr, Christina C;
    • Thalheimer, Raquel D;
    • Cambillo, Josephine V;
    • Beauchamp, Roberta L;
    • Shaikh, Ghalib;
    • Muzikansky, Alona;
    • Stemmer-Rachamimov, Anat;
    • Giovannini, Marco;
    • Kalamarides, Michel;
    • Barker, Fred G;
    • Ramesh, Vijaya;
    • Plotkin, Scott R
    Publication type:
    Article
    16

    Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 4, p. 1, doi. 10.1093/jnci/djv017
    By:
    • Ager, Eleanor I.;
    • Kozin, Sergey V.;
    • Kirkpatrick, Nathaniel D.;
    • Seano, Giorgio;
    • Kodack, David P.;
    • Askoxylakis, Vasileios;
    • Yuhui Huang;
    • Goel, Shom;
    • Snuderl, Matija;
    • Muzikansky, Alona;
    • Finkelstein, Dianne M.;
    • Dransfield, Daniel T.;
    • Devy, Laetitia;
    • Boucher, Yves;
    • Dai Fukumura;
    • Jain, Rakesh K.
    Publication type:
    Article
    17
    18

    Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.

    Published in:
    Science Translational Medicine, 2021, v. 13, n. 602, p. 1, doi. 10.1126/scitranslmed.abd4816
    By:
    • Wu, Limeng;
    • Vasilijic, Sasa;
    • Sun, Yao;
    • Chen, Jie;
    • Landegger, Lukas D.;
    • Zhang, Yanling;
    • Zhou, Wenjianlong;
    • Ren, Jun;
    • Early, Samuel;
    • Yin, Zhenzhen;
    • Ho, William W.;
    • Zhang, Na;
    • Gao, Xing;
    • Lee, Grace Y.;
    • Datta, Meenal;
    • Sagers, Jessica E.;
    • Brown, Alyssa;
    • Muzikansky, Alona;
    • Stemmer-Rachamimov, Anat;
    • Zhang, Luo
    Publication type:
    Article
    19
    20
    21

    Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results.

    Published in:
    2018
    By:
    • Schwamm, Lee H.;
    • Wu, Ona;
    • Song, Shlee S.;
    • Latour, Lawrence L.;
    • Ford, Andria L.;
    • Hsia, Amie W.;
    • Muzikansky, Alona;
    • Betensky, Rebecca A.;
    • Yoo, Albert J.;
    • Lev, Michael H.;
    • Boulouis, Gregoire;
    • Lauer, Arne;
    • Cougo, Pedro;
    • Copen, William A.;
    • Harris, Gordon J.;
    • Warach, Steven;
    • On Behalf Of The Mr Witness Investigators;
    • Mr Witness Investigators
    Publication type:
    journal article
    22

    Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 815, doi. 10.1007/s00280-020-04176-z
    By:
    • Do, Khanh T.;
    • O'Sullivan Coyne, Geraldine;
    • Hays, John L.;
    • Supko, Jeffrey G.;
    • Liu, Stephen V.;
    • Beebe, Kristin;
    • Neckers, Len;
    • Trepel, Jane B.;
    • Lee, Min-Jung;
    • Smyth, Tomoko;
    • Gannon, Courtney;
    • Hedglin, Jennifer;
    • Muzikansky, Alona;
    • Campos, Susana;
    • Lyons, John;
    • Ivy, Percy;
    • Doroshow, James H.;
    • Chen, Alice P.;
    • Shapiro, Geoffrey I.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 3, p. 603, doi. 10.1007/s11060-016-2332-5
    By:
    • Kalpathy-Cramer, Jayashree;
    • Chandra, Vyshak;
    • Da, Xiao;
    • Ou, Yangming;
    • Emblem, Kyrre;
    • Muzikansky, Alona;
    • Cai, Xuezhu;
    • Douw, Linda;
    • Evans, John;
    • Dietrich, Jorg;
    • Chi, Andrew;
    • Wen, Patrick;
    • Stufflebeam, Stephen;
    • Rosen, Bruce;
    • Duda, Dan;
    • Jain, Rakesh;
    • Batchelor, Tracy;
    • Gerstner, Elizabeth
    Publication type:
    Article
    36
    37

    Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 297, doi. 10.1007/s11060-014-1631-y
    By:
    • Norden, Andrew;
    • Schiff, David;
    • Ahluwalia, Manmeet;
    • Lesser, Glenn;
    • Nayak, Lakshmi;
    • Lee, Eudocia;
    • Rinne, Mikael;
    • Muzikansky, Alona;
    • Dietrich, Jorg;
    • Purow, Benjamin;
    • Doherty, Lisa;
    • LaFrankie, Debra;
    • Pulverenti, Julee;
    • Rifenburg, Jennifer;
    • Ruland, Sandra;
    • Smith, Katrina;
    • Gaffey, Sarah;
    • McCluskey, Christine;
    • Ligon, Keith;
    • Reardon, David
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain.

    Published in:
    Molecular Neurodegeneration, 2017, v. 12, p. 1, doi. 10.1186/s13024-017-0169-9
    By:
    • Arbel-Ornath, Michal;
    • Hudry, Eloise;
    • Boivin, Josiah R.;
    • Hashimoto, Tadafumi;
    • Takeda, Shuko;
    • Kuchibhotla, Kishore V.;
    • Hou, Steven;
    • Lattarulo, Carli R.;
    • Belcher, Arianna M.;
    • Shakerdge, Naomi;
    • Trujillo, Pariss B.;
    • Muzikansky, Alona;
    • Betensky, Rebecca A.;
    • Hyman, Bradley T.;
    • Bacskai, Brian J.
    Publication type:
    Article
    48
    49

    The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.

    Published in:
    Oncologist, 2024, v. 29, n. 7, p. 609, doi. 10.1093/oncolo/oyae107
    By:
    • Chang, Allison E B;
    • Piper-Vallillo, Andrew J;
    • Mak, Raymond H;
    • Lanuti, Michael;
    • Muzikansky, Alona;
    • Rotow, Julia;
    • Jänne, Pasi A;
    • Mino-Kenudson, Mari;
    • Swanson, Scott;
    • Wright, Cameron D;
    • Kozono, David;
    • Marcoux, Paul;
    • Piotrowska, Zofia;
    • Sequist, Lecia V;
    • Willers, Henning
    Publication type:
    Article
    50

    Phase II Study of Cabozantinib in Patients With Bone Metastasis.

    Published in:
    Oncologist, 2022, v. 27, n. 7, p. 600, doi. 10.1093/oncolo/oyac083
    By:
    • Choy, Edwin;
    • Cote, Gregory M;
    • Michaelson, M Dror;
    • Wirth, Lori;
    • Gainor, Justin F;
    • Muzikansky, Alona;
    • Sequist, Lecia V;
    • Sullivan, Ryan J;
    • Fidias, Panagiotis M;
    • Shaw, Alice;
    • Heist, Rebecca S
    Publication type:
    Article